The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
We identified a series of novel 7-phenyl benzoxaborole compounds with activity against Mycobacterium tuberculosis. Compounds had a range of activity with inhibitory concentrations (IC90) as low as 5.1M and no cytotoxicity against eukaryotic cells (IC50>50M). Compounds were active against intracellular mycobacteria cultured in THP-1 macrophages. We isolated and characterized resistant mutants with mutations in NADH dehydrogenase (Ndh) or the regulatory protein Mce3R. Mutations suggest that Ndh may be the target of this series.